Medical NetMedical Net , Inc.3645東証グロース情報・通信業FY ending May 2026, consolidated, J-GAAP

Medical Net revenue and profit

Out of every ¥100 of sales, about ¥3 is left as operating profit. Revenue changed +10.8% from the prior year, operating profit +94.0%.

Five-year trend

Revenue¥6.73B
FY ending May 2022: ¥3.75B¥3.75BFY ending May 2023: ¥4.5B¥4.5BFY ending May 2024: ¥5.25B¥5.25BFY ending May 2025: ¥6.08B¥6.08BFY ending May 2026: ¥6.73B¥6.73BFY22FY23FY24FY25FY26
Operating income¥191.6M
FY ending May 2022: ¥445.1M¥445.1MFY ending May 2023: ¥379.6M¥379.6MFY ending May 2024: ¥298.3M¥298.3MFY ending May 2025: ¥98.8M¥98.8MFY ending May 2026: ¥191.6M¥191.6MFY22FY23FY24FY25FY26
Operating margin2.8%
FY ending May 2022: 11.9%11.9%FY ending May 2023: 8.4%8.4%FY ending May 2024: 5.7%5.7%FY ending May 2025: 1.6%1.6%FY ending May 2026: 2.8%2.8%FY22FY23FY24FY25FY26

What drives ROE

Net margin × asset turnover = ROA; ROA × financial leverage = ROE

Net margin2.0%
Asset turnover1.56×
ROA3.2%
ROA3.2%
Financial leverage2.39×
ROE7.6%

Denominators: average assets and average equity. Derived from reported values; ROE is shown only for positive profit and equity.

Net margin2.0%
2022: 10.1%10.1%2023: 2.6%2.6%2024: 0.1%0.1%2026: 2.0%2.0%2223242526
Asset turnover1.56×
2022: 1.19×1.19×2023: 1.36×1.36×2024: 1.41×1.41×2026: 1.56×1.56×2223242526
ROA3.2%
2022: 12.1%12.1%2023: 3.5%3.5%2024: 0.2%0.2%2025: -1.7%-1.7%2026: 3.2%3.2%2223242526
Financial leverage2.39×
2022: 1.86×1.86×2023: 1.85×1.85×2024: 1.98×1.98×2026: 2.39×2.39×2223242526
ROE7.6%
2022: 22.5%22.5%2023: 6.5%6.5%2024: 0.3%0.3%2026: 7.6%7.6%2223242526
PeriodNet marginAsset turnoverROAFinancial leverageROE
202210.1%1.19×12.1%1.86×22.5%
20232.6%1.36×3.5%1.85×6.5%
20240.1%1.41×0.2%1.98×0.3%
2025——×-1.7%—×—
20262.0%1.56×3.2%2.39×7.6%

Financial leverage can raise ROE; a higher value alone does not describe a company's overall condition.

Asset intensity and goodwill

Annual trends in tangible-asset ratios and goodwill balance.

PPE ÷ revenue1.7%
2021: 1.4%1.4%2022: 2.8%2.8%2023: 2.5%2.5%2024: 2.4%2.4%2025: 2.2%2.2%2026: 1.7%1.7%212223242526
PPE ÷ total assets2.5%
2021: 1.9%1.9%2022: 3.4%3.4%2023: 3.2%3.2%2024: 3.1%3.1%2025: 3.3%3.3%2026: 2.5%2.5%212223242526
Goodwill ÷ parent equity19.4%
2021: 15.2%15.2%2022: 27.0%27.0%2023: 15.5%15.5%2024: 22.9%22.9%2025: 23.5%23.5%2026: 19.4%19.4%212223242526
Goodwill balance¥376.8M
2021: ¥188.4M¥188.4M2022: ¥457.3M¥457.3M2023: ¥293.6M¥293.6M2024: ¥429.9M¥429.9M2025: ¥394.2M¥394.2M2026: ¥376.8M¥376.8M212223242526

Ratios are derived from reported values. Goodwill is shown only when separately reported; it is not inferred from combined intangible assets. Definition

Investment and working-capital efficiency

Track R&D investment and how long operating capital remains tied up before sales turn into cash.

R&D spending—
2021: ¥11.9M¥11.9M2022: ¥8M¥8M2024: ¥7.1M¥7.1M2025: ¥23.9M¥23.9M212223242526
R&D / revenue—
2021: 0.4%0.4%2022: 0.2%0.2%2024: 0.1%0.1%2025: 0.4%0.4%212223242526

R&D is shown only for years with machine-readable disclosure. Days are estimates using year-end receivables, inventory and payables divided by annual revenue or cost of sales; financial companies are excluded.

Income statement (JPY millions)

ItemFY ending May 2022FY ending May 2023FY ending May 2024FY ending May 2025FY ending May 2026
Revenue3,7464,5015,2526,0786,732
Cost of revenue2,2862,7203,4114,1124,735
Gross profit1,4601,7811,8411,9661,997
SG&A1,0151,4011,5431,8671,805
Operating income44538029899192
Pretax income53425115325259
Income tax1381421276396
Net income attributable to owners3801166-68137
Operating margin11.9%8.4%5.7%1.6%2.8%

Balance sheet (reported items)

Year-end figures from filings. Unreported items are omitted. Interest-bearing debt excludes lease liabilities.

Assets

Cash 42%
3%
Intangibles and goodwill 17%
1%
Other assets 37%

Funding

Other liabilities 55%
Equity 45%

Each bar totals 100% of assets; other is the residual.

ItemFY ending May 2022FY ending May 2023FY ending May 2024FY ending May 2025FY ending May 2026
Cash and equivalents¥1.13B¥1.51B¥1.51B¥1.4B¥1.92B
Total assets¥3.15B¥3.47B¥3.99B¥4.08B¥4.57B
Net assets¥1.73B¥1.93B¥1.93B¥1.77B¥2.07B
Share capital¥286M¥286M¥286M¥286M¥286M
Property, plant and equipment¥106.2M¥111.4M¥125.6M¥133.2M¥114.8M
Intangible assets excluding goodwill¥472.8M¥306M¥460.3M¥428.1M¥417.7M
Goodwill¥457.3M¥293.6M¥429.9M¥394.2M¥376.8M
Investment securities¥75.7M¥62.2M¥59.2M¥55.7M¥52.7M
Current assets¥2.08B¥2.46B¥2.83B¥2.96B¥3.6B
Current liabilities¥1.3B¥1.44B¥1.62B¥1.93B¥2.19B
Short-term borrowings¥630M¥680.5M¥530.4M¥846.2M¥1.09B
Long-term borrowings¥111.3M¥82.6M¥387M¥336.3M¥267.8M
Total liabilities¥1.42B¥1.54B¥2.06B¥2.31B¥2.5B
Non-controlling interests¥29.6M¥12M¥24.7M¥53M¥71.9M
Equity attributable to owners of parent¥1.69B¥1.89B¥1.87B¥1.68B¥1.94B
Retained earnings¥1.63B¥1.71B¥1.69B¥1.6B¥1.71B
Treasury stock-¥511.4M-¥443.7M-¥443.7M-¥543.7M-¥400.2M

Sources

Show source documents (6)
  • EDINET (FSA Japan)

    有価証券報告書-第25期(2025/06/01-2026/05/31)

    ID S100YYS42026-08-26Open
  • EDINET (FSA Japan)

    有価証券報告書-第24期(2024/06/01-2025/05/31)

    ID S100WLO92025-08-27Open
  • EDINET (FSA Japan)

    訂正有価証券報告書-第23期(2023/06/01-2024/05/31)

    ID S100UBP92024-09-04Open
  • EDINET (FSA Japan)

    有価証券報告書-第22期(2022/06/01-2023/05/31)

    ID S100RS9E2023-08-31Open
  • EDINET (FSA Japan)

    有価証券報告書-第21期(令和3年6月1日-令和4年5月31日)

    ID S100P43U2022-08-31Open
  • EDINET (FSA Japan)

    有価証券報告書-第20期(令和2年6月1日-令和3年5月31日)

    ID S100MD7Q2021-08-31Open

Extracted from XBRL: 51 / Derived from other figures: 1

Spotted an error? Report it (corrections keep the original record)

Analyze this page with AI

Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.